Bio Answer Holdings

Bio-Answer is a South Korean biotechnology company specializing in advanced molecular diagnostic solutions. The company has developed a proprietary "Fast PCR" platform that significantly reduces the time required for nucleic acid amplification while maintaining high sensitivity and specificity. Bio-Answer's product portfolio includes diagnostic kits for clinical infectious diseases, such as COVID-19, as well as comprehensive testing solutions for food safety and animal health. By streamlining the PCR process, the company provides rapid and reliable results for pathogens like Salmonella, Listeria, and various respiratory viruses. Bio-Answer serves a global market, providing critical diagnostic tools to laboratories, food processing facilities, and clinical settings.